Investment
Features
FeesSafety
Academy
More
Pluang+

ADMA Biologics to report Q1 2026 earnings on May 6 with live conference call

Company Fundamentals
29 Apr 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

ADMA Biologics, a U.S.-based biopharmaceutical company, will announce its first quarter 2026 financial results on May 6, 2026, after market close. The company will host a live conference call at 4:30 p.m. ET to discuss the results and provide updates. ADMA specializes in manufacturing and marketing plasma-derived biologics for immune deficiencies and infectious diseases. Investors can register to join the call or listen via webcast, with a replay available on the company website.

More News (ADMA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App